[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:pizz":3},{"name":4,"total":5,"recruiting":5,"trials":6},"PiZZ",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06389877","A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:23.750999Z","2026-05-05T02:43:28.963180Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06165341","Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)",[19],"Phase 3","2026-08-26T02:17:16.980188Z","2026-05-05T02:43:27.102194Z"]